L01XX11 • estramustine • Antineoplastic and immunomodulating agents | Other antineoplastic agents
Estramustine is a medication used in the treatment of advanced prostate cancer. It works by combining hormonal and cytotoxic effects, inhibiting the growth and multiplication of cancer cells.
Estramustine is administered orally as capsules, according to the oncologist's instructions. The dose and duration of treatment are determined individually, depending on the stage of the disease and the patient's response to therapy.
Side effects may include nausea, vomiting, swelling of the limbs, fatigue, digestive disorders, or, rarely, allergic reactions and an increased risk of thrombosis. Medical monitoring is necessary throughout the treatment.
Estramustine is an important option for patients with advanced prostate cancer, helping to slow disease progression and improve quality of life.
Substance: estramustine
Date of last drug list: 01-07-2013
Commercial code: W07049003
Concentration: 140mg
Pharmaceutical form: capsules
Quantity: 100
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).